| Literature DB >> 16704828 |
Amelia C Crampin1, Judith R Glynn, Hamidou Traore, Malcolm D Yates, Lorren Mwaungulu, Michael Mwenebabu, Steven D Chaguluka, Sian Floyd, Francis Drobniewski, Paul E M Fine.
Abstract
We conducted the first molecular study of tuberculosis (TB) to estimate the role of household contact and transmission from HIV-positive putative source contacts (PSCs) in a high HIV-prevalence area. TB patients in a long-term population-based study in Malawi were asked about past contact with TB. DNA fingerprinting was used to define clusters of cases with identical strains. Among 143 epidemiologically defined PSC-case pairs, fingerprinting confirmed transmission for 44% of household and family contacts and 18% of other contacts. Transmission was less likely to be confirmed if the PSC were HIV positive than if he or she was HIV negative (odds ratio 0.32, 95% confidence interval [CI] 0.14-0.74). Overall, epidemiologic links were found for 11% of 754 fingerprint-clustered cases. We estimate that 9%-13% of TB cases were attributable to recent transmission from identifiable close contacts and that nearly half of the TB cases arising from recent infection had acquired the infection from HIV-positive patients.Entities:
Mesh:
Year: 2006 PMID: 16704828 PMCID: PMC3374426 DOI: 10.3201/eid1205.050789
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Comparison of Mycobacterium tuberculosis strains of index cases and putative source contacts (PSCs)
| Comparison of strains, no. (%) | ||||||
|---|---|---|---|---|---|---|
| Identical | 1–4 bands different and first example of new strain | 1–4 bands different and not first example | >4 bands different | Total | ||
| Total | 51 (25.5) | 8 (4.0) | 15 (7.5) | 126 (63.0) | 200 | |
| Source of linking information | ||||||
| Database only | 9 (25.7) | 1 (2.9) | 5 (14.3) | 20 (57.1) | 35 | |
| History only | 14 (16.5) | 4 (4.7) | 6 (7.1) | 61 (71.8) | 85 | |
| Both | 28 (35.0) | 3 (3.8) | 4 (5.0) | 45 (56.3) | 80 | |
| Characteristic of PSC in case-PSC pairs | ||||||
| Smear-positive pulmonary | 48 (28.7) | 7 (4.2) | 15 (9.0) | 97 (58.1) | 167 | |
| Smear-negative pulmonary | 2 (9.1) | 1 (4.6) | 0 (0.0) | 19 (86.4) | 22 | |
| Extrapulmonary | 1 (9.1) | 0 (0.0) | 0 (0.0) | 10 (90.9) | 11 | |
| No. bands in RFLP* of PSC | ||||||
| <5 | 6 (40.0) | 1 (6.7) | 0 (0.0) | 8 (53.3) | 15 | |
| 5–10 | 17 (22.7) | 6 (8.0) | 8 (10.7) | 44 (58.7) | 75 | |
| >10 | 28 (25.5) | 1 (0.9) | 7 (6.4) | 74 (67.3) | 110 | |
*RFLP, restriction fragment length polymorphism.
Probability of transmission from a smear-positive putative source contact (PSC) being confirmed by restriction fragment length polymorphism, according to characteristics of case and PSC
| Characteristic | Confirmed/ total pairs (%) | p | Odds ratio, 95% confidence interval (adjusted for closeness of contact) | |
|---|---|---|---|---|
| Closeness of contact | ||||
| Same household | 22/50 (44.0) | 3.6 (1.4–9.3) | ||
| Close family, not household | 17/38 (44.7) | 3.5 (1.5–8.6) | ||
| Other | 10/55 (18.2) | 0.006 | Referent | |
| Time between diagnosis of disease in PSC and case-patient (mo) | ||||
| <12 | 21/62 (33.9) | Referent | ||
| 12–23 | 13/36 (36.1) | 1.1 (0.44–2.6) | ||
| >24 | 15/45 (33.3) | 1.0 | 0.88 (0.37–2.1) | |
| Age of case-patient (y) | ||||
| <30 | 20/53 (37.7) | Referent | ||
| 30–44 | 23/67 (34.3) | 0.72 (0.32–1.6) | ||
| >45 | 6/23 (26.1) | 0.3 (trend) | 0.48 (0.17–1.3) | |
| Age of PSC (y) | ||||
| <30 | 20/49 (40.8) | Referent | ||
| 30–44 | 21/63 (33.3) | 0.93 (0.42–2.1) | ||
| >45 | 8/31 (25.8) | 0.2 (trend) | 0.59 (0.19–1.8) | |
| Sex of case-patient | ||||
| Female | 28/81 (34.6) | 0.9 | Referent | |
| Male | 21/62 (33.9) | 1.2 (0.56–2.4) | ||
| Sex of PSC | ||||
| Female | 33/75 (44.0) | 0.01 | Referent | |
| Male | 16/68 (23.5) | 0.46 (0.21–0.99) | ||
| HIV status of case-patient | ||||
| HIV negative | 16/37 (43.2) | 0.1 | Referent | |
| HIV positive | 19/67 (28.4) | 0.55 (0.23–1.3) | ||
| HIV status of PSC | ||||
| HIV negative | 27/59 (45.8) | 0.01 | Referent | |
| HIV positive | 15/62 (24.2) | 0.32 (0.14–0.74) | ||
| Drug resistance of PSC | ||||
| None | 42/129 (32.6) | 0.2 | Referent | |
| Isoniazid resistant | 7/14 (50.0) | 2.1 (0.66–6.8) | ||
| Smear positivity of PSC | ||||
| 1+ | 5/18 (27.8) | Referent | ||
| 2+ | 12/36 (33.3) | 0.94 (0.26–3.5) | ||
| 3+ | 12/43 (27.9) | 0.89 (0.25–3.2) | ||
| 4+ | 20/46 (43.5) | 0.4 | 1.6 (0.46–5.4) | |
Proportion of clustered strains with epidemiologic links
| No. with epidemiologic links within a cluster | Total with clustered strains | % with link | ||
|---|---|---|---|---|
| Total | 84 | 754 | 11.1 | |
| No. bands | ||||
| >5 | 72 | 679 | 10.6 | |
| <5 | 12 | 75 | 16.0 | |
| Cluster size (strains with >5 bands only) | ||||
| Cluster 2–4 | 18 | 187 | 9.6 | |
| Cluster 5–9 | 24 | 152 | 15.8 | |
| Cluster >10 | 30 | 340 | 8.8 | |